142 related articles for article (PubMed ID: 16645716)
1. Gemistocytes in astrocytomas: are they a significant prognostic factor?
Martins DC; Malheiros SM; Santiago LH; Stávale JN
J Neurooncol; 2006 Oct; 80(1):49-55. PubMed ID: 16645716
[TBL] [Abstract][Full Text] [Related]
2. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
3. The significance of gemistocytes in astrocytoma.
Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
[TBL] [Abstract][Full Text] [Related]
4. [Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)].
Martins DC; Stávale JN; Malheiros SM; Santiago LH; Roman LC; Aguiar KC
Arq Neuropsiquiatr; 2001 Dec; 59(4):926-31. PubMed ID: 11733839
[TBL] [Abstract][Full Text] [Related]
5. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
[TBL] [Abstract][Full Text] [Related]
6. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
Reis RM; Hara A; Kleihues P; Ohgaki H
Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
[TBL] [Abstract][Full Text] [Related]
7. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
8. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
10. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
11. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
12. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
13. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas.
Tihan T; Davis R; Elowitz E; DiCostanzo D; Moll U
Arch Pathol Lab Med; 2000 Jan; 124(1):108-13. PubMed ID: 10629140
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
[TBL] [Abstract][Full Text] [Related]
15. bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status.
Newcomb EW; Bhalla SK; Parrish CL; Hayes RL; Cohen H; Miller DC
Acta Neuropathol; 1997 Oct; 94(4):369-75. PubMed ID: 9341939
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
[TBL] [Abstract][Full Text] [Related]
17. p53 and PTEN gene mutations in gemistocytic astrocytomas.
Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
[TBL] [Abstract][Full Text] [Related]
18. Cerebral granular cell astrocytomas: a Mib-1, bcl-2, and telomerase study.
Chorny JA; Evans LC; Kleinschmidt-DeMasters BK
Clin Neuropathol; 2000; 19(4):170-9. PubMed ID: 10919348
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of histological features in diffuse astrocytomas WHO grade II.
Lind-Landström T; Habberstad AH; Sundstrøm S; Torp SH
Int J Clin Exp Pathol; 2012; 5(2):152-8. PubMed ID: 22400076
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]